ClinicalTrials.gg
CompletedNCT07820449Updated Sep 15, 2026

Ankle Evertor and Invertor Strength Training

An interventional study of Ankle Evertor and Invertor Strength Training in Ankle Rehabilitation, Ankle Instability and Ankle Sprain, sponsored by University of Ljubljana. Completed at 1 site in Slovenia. Open to male participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by University of Ljubljana · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 years 7 months after the study started (first participant enrolled Feb 2017, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Male
01

Study summary

The aim of this study was to investigate the effects of a 12-week ankle evertor and invertor strength training program performed on a specially designed device, which allows isolated strengthening of evertor and invertor muscles. Outcome measures included isometric ankle torque, EMG activity of six tibial muscles, muscle coactivation, and kinematic parameters during three walking conditions. This trial was retrospectively registered. The study was conducted in 2017 as part of a doctoral dissertation at the Faculty of Sport, University of Ljubljana, prior to the authors' awareness of prospective registration requirements.

02

Conditions studied

  • Ankle Rehabilitation
  • Ankle Instability
  • Ankle Sprain
  • Ankle Injuries and Disorders

Keywords

  • ankle evertors
  • ankle invertors
  • ankle joint
  • strength training
  • subtalar axis
  • peroneal muscles
  • tibial muscles
  • ankle sprains
03

In context

Ankle Injuries

350 studies on the registry are indexed under Ankle Injuries; 74 are open to participants now.

This study's enrollment of 32 is below the median of 54 across 270 interventional studies indexed under Ankle Injuries.

Browse Ankle Injuries studies →

Lead sponsor

University of Ljubljana is the lead sponsor of 43 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male, aged 18 to 50 Years
  • Recreationally active (regularly participating in running or sport)
  • No history of ankle injury or surgery
  • No musculoskeletal disorders affecting the lower extremity
  • Able to perform physical exercise without restrictions

Exclusion criteria

Exclusion Criteria:

  • History of ankle sprain or ligament injury in the past 12 months
  • Any lower extremity injury or surgery
  • Neurological or cardiovascular conditions affecting exercise participation
  • Currently receiving physiotherapy for lower extremity conditions
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Experimental Group

    Participants performed a 12-week ankle evertor and invertor strength training program on a specially designed device.

    Behavioral: Ankle Evertor and Invertor Strength Training

  • No intervention
    Control Group

    Participants maintained habitual activity without any structured strength training.

Interventions

  • BehavioralAnkle Evertor and Invertor Strength Training

    Participants in experimental group were performing strength training on a specially designed device. The program consisted of 8 weeks of hypertrophy-oriented training followed by 4 weeks of neural activation training.

06

What researchers measure

Primary outcomes

  1. Isometric Ankle Torque

    Maximal isometric torque in foot eversion and inversion direction measured with a isometric device.

    Time frame: Baseline and 12 weeks

Secondary outcomes

  1. EMG Activity of Tibial Muscles

    Monitoring normalized RMS EMG amplitude of peroneus longus, peroneus brevis, tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and soleus during different walking conditions.

    Time frame: Baseline and 12 weeks

  2. Walking Speed

    Monitoring walking speed (m/s) during three walking conditions.

    Time frame: Baseline and 12 weeks

  3. Stretch Reflex Response

    Electromyographic reflex response of ankle evertor (m. PL and PB) and invertor muscles (m TA) following mechanical perturbation.

    Time frame: Baseline and 12 weeks

  4. Muscle Co-activation Index Between Pairs of Tibial Muscles During Walking

    Coactivation index (%) calculated between pairs of tibial muscles (PL, PB, TA, SOL, GM, GL) during three different types of walking (normal walking, medially inclined, laterally inclined surface).

    Time frame: Baseline and 12 weeks

  5. Foot Position During Walking

    Monitoring foot elevation angle (degrees) during three different types of walking.

    Time frame: Baseline and 12 weeks

  6. Contact Time

    Monitoring contact time (s) during three different types of walking (flat surface, medially inclined laterally inclined).

    Time frame: Baseline and 12 weeks

  7. Stride Length

    Monitoring stride length (m) during three different types of walking (flat surface, medially inclined, laterally inclined).

    Time frame: Baseline and 12 weeks

07

Study locations

1 site
  • Faculty of Sport, University of Ljubljana
    Ljubljana, 1000, Slovenia
08

References and documents

Publications

  • Winter DA, Patla AE, Frank JS, Walt SE. Biomechanical walking pattern changes in the fit and healthy elderly. Phys Ther. 1990 Jun;70(6):340-7. doi: 10.1093/ptj/70.6.340. PubMed 2345777 ↗
  • Voloshina AS, Ferris DP. Biomechanics and energetics of running on uneven terrain. J Exp Biol. 2015 Mar;218(Pt 5):711-9. doi: 10.1242/jeb.106518. Epub 2015 Jan 23. PubMed 25617451 ↗
  • Santilli V, Frascarelli MA, Paoloni M, Frascarelli F, Camerota F, De Natale L, De Santis F. Peroneus longus muscle activation pattern during gait cycle in athletes affected by functional ankle instability: a surface electromyographic study. Am J Sports Med. 2005 Aug;33(8):1183-7. doi: 10.1177/0363546504274147. Epub 2005 Jul 6. PubMed 16000658 ↗
  • Murley GS, Menz HB, Landorf KB. Foot posture influences the electromyographic activity of selected lower limb muscles during gait. J Foot Ankle Res. 2009 Nov 26;2:35. doi: 10.1186/1757-1146-2-35. PubMed 19939283 ↗
  • Louwerens JW, van Linge B, de Klerk LW, Mulder PG, Snijders CJ. Peroneus longus and tibialis anterior muscle activity in the stance phase. A quantified electromyographic study of 10 controls and 25 patients with chronic ankle instability. Acta Orthop Scand. 1995 Dec;66(6):517-23. doi: 10.3109/17453679509002306. PubMed 8553819 ↗
  • Ha SC, Fong DT, Chan KM. Review of ankle inversion sprain simulators in the biomechanics laboratory. Asia Pac J Sports Med Arthrosc Rehabil Technol. 2015 Oct 21;2(4):114-121. doi: 10.1016/j.asmart.2015.08.002. eCollection 2015 Oct. PubMed 29264250 ↗
  • Garrick JG. The frequency of injury, mechanism of injury, and epidemiology of ankle sprains. Am J Sports Med. 1977 Nov-Dec;5(6):241-2. doi: 10.1177/036354657700500606. No abstract available. PubMed 563179 ↗
  • Ferran NA, Maffulli N. Epidemiology of sprains of the lateral ankle ligament complex. Foot Ankle Clin. 2006 Sep;11(3):659-62. doi: 10.1016/j.fcl.2006.07.002. PubMed 16971255 ↗
  • Falconer K, Winter DA. Quantitative assessment of co-contraction at the ankle joint in walking. Electromyogr Clin Neurophysiol. 1985 Mar-Apr;25(2-3):135-49. No abstract available. PubMed 3987606 ↗
  • Docherty CL, Moore JH, Arnold BL. Effects of strength training on strength development and joint position sense in functionally unstable ankles. J Athl Train. 1998 Oct;33(4):310-4. PubMed 16558526 ↗
  • DeMers MS, Hicks JL, Delp SL. Preparatory co-activation of the ankle muscles may prevent ankle inversion injuries. J Biomech. 2017 Feb 8;52:17-23. doi: 10.1016/j.jbiomech.2016.11.002. Epub 2016 Dec 7. PubMed 28057351 ↗
  • Chan CW, Rudins A. Foot biomechanics during walking and running. Mayo Clin Proc. 1994 May;69(5):448-61. doi: 10.1016/s0025-6196(12)61642-5. PubMed 8170197 ↗
  • Brockett CL, Chapman GJ. Biomechanics of the ankle. Orthop Trauma. 2016 Jun;30(3):232-238. doi: 10.1016/j.mporth.2016.04.015. PubMed 27594929 ↗
  • Bavdek R, Zdolsek A, Strojnik V, Dolenec A. Peroneal muscle activity during different types of walking. J Foot Ankle Res. 2018 Sep 3;11:50. doi: 10.1186/s13047-018-0291-0. eCollection 2018. PubMed 30202446 ↗
  • Apps C, Sterzing T, O'Brien T, Lake M. Lower limb joint stiffness and muscle co-contraction adaptations to instability footwear during locomotion. J Electromyogr Kinesiol. 2016 Dec;31:55-62. doi: 10.1016/j.jelekin.2016.09.003. Epub 2016 Sep 20. PubMed 27684529 ↗

Individual participant data

Plan to share: Yes — Individual participant data may be shared upon reasonable request to the corresponding author.

Supporting information: Informed consent form

Time frame: Following publication of study results

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2017 to primary completion in May 2017, 3 months.

Of 138 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 3 months is below that.

Counting every sponsor, half of 141 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2026
First posted
Sep 15, 2026
StartActual
Feb 2, 2017
Primary completionActual
May 31, 2017
CompletionActual
May 31, 2017
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07820449
Lead sponsor
University of Ljubljana
Responsible party
Sponsor
First posted
Sep 15, 2026
Start date
Feb 2, 2017
Primary completion
May 31, 2017
Completion
May 31, 2017
Last update
Sep 15, 2026

Study contacts

Aleš Dolenec, PhD
study chair · University of Ljubljana
Rok Bavdek, PhD
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion